Jemperli was the first drug in the class to be approved for front-line use in endometrial cancer last year, based on progression-free survival data from RUBY, but with a restricted label that ...

The failure of Roche's tiragolumab in the SKYSCRAPER-01 trial in on-small cell lung cancer (NSCLC) has cast a pall over the TIGIT class ... GSK's PD-1 inhibitor Jemperli (dostarlimab), and ...

Also in Europe, officials have endorsed GSK's Jemperli to treat all adult patients with primary advanced or recurrent endometrial cancer, including those with mismatch repair proficient (MMRp ...

In Dungeons and Dragons, choosing one of the 14 DnD classes might be the most important decision you can make. D&D classes shape the way you play, allowing you to wield axes, cast spells, or even ...

Teva Pharmaceutical Industries Ltd. ADR-2.66% $19.77B ...